
Methyl phenobarbital is a barbiturate derivative with sedative, hypnotic, and anticonvulsant properties, primarily used in the synthesis of medications for epilepsy and anxiety disorders.
In the field of antiepileptic drug development, the stability of barbiturate salts is essential for maintaining therapeutic windows. Manufacturers specifically select Methyl phenobarbital because its N-methyl group enhances lipid solubility, allowing for effective absorption and gradual metabolic release. For instance, it is a key component in the treatment of grand mal and petit mal seizures. Consequently, it facilitates sustained neuronal stabilization. As a result, Zyntex ensures that our industrial-grade material adheres to the highest purity standards to ensure consistent bioavailability in final pharmaceutical dosages.
Moreover, Methyl phenobarbital is often studied in the context of comparative sedative pharmacology. In neurological research, researchers may evaluate its performance alongside other central nervous system stimulants like Methylphenidate hydrochloride to understand the balance of inhibitory and excitatory pathways. This application is vital for developing balanced neuropsychiatric treatments. Undoubtedly, this pushes the boundaries of behavioral medicine. At the same time, formulating these potent APIs requires high-purity solvents for crystallization and analytical testing. For precise laboratory separations, Methylcyclohexane is frequently utilized as a stable hydrocarbon solvent. In short, our product serves as a fundamental building block for advanced sedative and anticonvulsant science.
Recently, scientific interest has increased regarding the hepatic metabolism of barbiturates and their interaction with enzymatic pathways. Researchers apply Methyl phenobarbital in pharmacokinetic models, sometimes comparing its metabolic profile to cardiovascular regulators like Metoprolol tartrate to assess potential drug-drug interactions in geriatric patients. Because of this, Zyntex offers secure, moisture-proof packaging to maintain the chemical integrity of the API during global transit. Ultimately, you secure a reliable supply partner by choosing Zyntex. We balance stringent regulatory compliance with technical chemical expertise. To conclude, our commitment to chemical excellence ensures that your manufacturing processes achieve the highest levels of clinical reliability.
This pharmaceutical-grade barbiturate is specifically vital in the following four sectors:
Zyntex supplies Methyl phenobarbital for anticonvulsant formulations; thus supporting long-term seizure control in clinical patients.
Used as an active ingredient in sedative synthesis; consequently it is a staple in controlled drug manufacturing.
Manufacturers use it for GABA receptor studies; undoubtedly essential for exploring the mechanisms of neural inhibition.
Zyntex provides high-purity API for animal sedative applications; specifically helping to manage canine and feline epilepsy.
| Parameter | Standard Value |
|---|---|
| Product Name | Methyl phenobarbital (Mephobarbital) |
| Assay (Purity) | Min. 99% |
| Appearance | White crystalline powder |
| CAS Number | 115-38-8 |
⚠️ Safety & Handling: Methyl phenobarbital is a controlled substance with potential for dependency. Therefore, it must be handled in strict accordance with local narcotics and pharmaceutical regulations. Avoid inhalation and skin contact.
For more detailed pharmacology and chemical structure analysis, visit: PubChem Database – Methyl phenobarbital (115-38-8)